Dystrophic cardiomyopathy: Amplification of cellular damage by Ca 2+ signalling and reactive oxygen species-generating pathways

Cardiovascular Research

Volumn 77, Issue 4, 2008, Pages 766-773

  Jung, Carole ^a   Martins, Adriano S ^b   Niggli, Ernst ^a   Shirokova, Natalia ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Calcium (cellular); Mitochondria; Myocytes; Oxygen radicals; SR (function)

Indexed keywords

CALCIUM; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL DAMAGE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DYSTROPHIC CARDIOMYOPATHY; FLUORESCENCE ANALYSIS; HEART VENTRICLE; INTRACELLULAR SPACE; MECHANICAL STRESS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; MUSCLE CELL; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CALCIUM SIGNALING; CARDIOMYOPATHIES; CELL DEATH; CYTOSOL; FREE RADICAL SCAVENGERS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED MDX; MICROSCOPY, CONFOCAL; MITOCHONDRIA, HEART; MUSCULAR DYSTROPHIES; MYOCYTES, CARDIAC; OSMOTIC PRESSURE; REACTIVE OXYGEN SPECIES; STRESS, MECHANICAL; TIME FACTORS;

EID: 39749095982     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm089     Document Type: Article

References (38)

1. Ervasti JM, Campbell KP. Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy. Mol Cell Biol Hum Dis Ser 1993;3:139-166.
2. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19.
3. Allen DG, Whitehead NP, Yeung EW. Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes. J Physiol 2005;567:723-735.
4. Rüegg UT, Nicolas-Metral V, Challet C, Bernard-Helary K, Dorchies OM, Wagner S et al. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul Disord 2002;12:S155- S161.
5. Wang X, Weisleder N, Collet C, Zhou J, Chu Y, Hirata Y et al. Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle. Nat Cell Biol 2005;7:525-530.
6. Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, Levin LS. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 2004;14:491-496.
7. Alderton JM, Steinhardt RA. How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 2000;10:268-272.
8. Guharay F, Sachs F. Stretch-activated single ion channel currents in tissue-cultured embryonic chick skeletal muscle. J Physiol 1984;352:685-701.
9. Tutdibi O, Brinkmeier H, Rüdel R, Fohr KJ. Increased calcium entry into dystrophin-deficient muscle fibres of mdx and adr-mdx mice is reduced by ion channel blockers. J Physiol 1999;515:859-868.
10. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90:3710-3714.
11. Danialou G, Comtois AS, Dudley R, Karpati G, Vincent G, Des Rosiers C et al. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J 2001;15:1655-1657.
12. Yue Y, Skimming JW, Liu M, Strawn T, Duan D. Full-length dystrophin expression in half of the heart cells ameliorates β-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet 2004;13:1669-1675.
13. Tidball JG, Albrecht DE, Lokensgard BE, Spencer MJ. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 1995;108:2197- 2204.
14. Mikhailov VM, Komarov SA, Nilova VK, Shtein GI, Baranov VS. Ultrastructural and morphometrical analysis of apoptosis stages in cardiomyocytes of mdx mice. Tsitologiia 2001;43:729-737.
15. Yasuda S, Townsend D, Michele DE, Favre EG, Day SM, Metzger JM. Dystrophic heart failure blocked by membrane sealant poloxamer. Nature 2005;436:1025-1029.
16. Williams IA, Allen DG. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol 2007;292:H846-H855.
17. 2+ signaling and ROS generating pathways in dystrophic cardiomyopathy. Biophys J 2007;92:255a.
18. 2+ release refractoriness in heart muscle. Circ Res 2004;95:807-813.
19. Wolska BM, Solaro RJ. Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol 1996;271:H1250-H1255.
20. 2+ release in permeabilized mammalian skeletal muscle fibres. J Physiol 2003;547:453-462.
21. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000;192:1001-1014.
22. 2+. J Physiol 2005;565:801-813.
23. 2+-measurements with visible wavelength indicators in isolated cardiac myocytes. Cell Calcium 1993;14:359-372.
24. 2+ from sarcoplasmic reticulum to mitochondria in skeletal muscle. J Biol Chem 2006;281:1547-1554.
25. Menke A, Jockusch H. Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J Cell Sci 1995;108:727- 733.
26. Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001;89:453-460.
27. Williams IA, Allen DG. The role of reactive oxygen species in the hearts of dystrophin-deficient (mdx) mice. Am J Physiol Heart Circ Physiol 2007;293:H1969-H1977.
28. Reinehr R, Gorg B, Becker S, Qvartskhava N, Bidmon HJ, Selbach O et al. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia 2007;55:758-771.
29. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287:C817-C833.
30. Hüser J, Blatter LA. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J 1999;343:311-317.
31. Yano M, Okuda S, Oda T, Tokuhisa T, Tateishi H, Mochizuki M et al. Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. Circulation 2005;112:3633-3643.
32. Yoshikawa Y, Hagihara H, Ohga Y, Nakajima-Takenaka C, Murata KY, Taniguchi S et al. Calpain inhibitor-1 protects the rat heart from ischemia-reperfusion injury: analysis by mechanical work and energetics. Am J Physiol Heart Circ Physiol 2005;288:H1690-H1698.
33. Davidson SM, Duchen MR. Calcium microdomains and oxidative stress. Cell Calcium 2006;40:561-574.
34. Payne TR, Oshima H, Sakai T, Ling Y, Gharaibeh B, Cummins J et al. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther 2005;12:1264-1274.
35. Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 2003;108:1626-1632.
36. Perkins KJ, Davies KE. The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscul Disord 2002;12:S78-S89.
37. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997;90:717-727.
38. Janssen PM, Hiranandani N, Mays TA, Rafael-Fortney JA. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 2005;289:H2373-H2378.